Cytotoxicity and Immunomodulatory Effects of Cannabidiol on Canine PBMCs: A Study in LPS-Stimulated and Epileptic Dogs

Cannabidiol, the primary non-psychoactive phytocannabinoid found in cannabis, has generated significant research interest due to its potential for biological effects, such as anti-inflammatory, analgesic, immunomodulatory, and anticonvulsant properties. Several studies have demonstrated the potentia...

Full description

Saved in:
Bibliographic Details
Main Authors: Phannicha Kosukwatthana, Oumaporn Rungsuriyawiboon, Jatuporn Rattanasrisomporn, Kanogwan Kimram, Natthasit Tansakul
Format: Article
Language:English
Published: MDPI AG 2024-12-01
Series:Animals
Subjects:
Online Access:https://www.mdpi.com/2076-2615/14/24/3683
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850050690318073856
author Phannicha Kosukwatthana
Oumaporn Rungsuriyawiboon
Jatuporn Rattanasrisomporn
Kanogwan Kimram
Natthasit Tansakul
author_facet Phannicha Kosukwatthana
Oumaporn Rungsuriyawiboon
Jatuporn Rattanasrisomporn
Kanogwan Kimram
Natthasit Tansakul
author_sort Phannicha Kosukwatthana
collection DOAJ
description Cannabidiol, the primary non-psychoactive phytocannabinoid found in cannabis, has generated significant research interest due to its potential for biological effects, such as anti-inflammatory, analgesic, immunomodulatory, and anticonvulsant properties. Several studies have demonstrated the potential of CBD to alter inflammatory cytokines; however, data on CBD’s effects on cell viability and pro-inflammatory cytokines in target animals, such as dogs, are limited. Therefore, in this study, we investigated the effects of CBD on the cell viability and modulation of pro-inflammatory cytokines, such as interleukin (IL)-1β, IL-6, and tumor necrosis factor-α (TNF-α), in canine PBMCs stimulated with LPS. To evaluate the effect of CBD on neuroinflammation in epilepsy pathology, an independent study of five refractory epileptic dogs co-treated with CBD for 30 days was conducted. The current findings revealed that CBD concentrations of 16 µg/mL had a statistically significant effect on the viability of canine PBMCs with a calculated IC<sub>50</sub> of 15.54 µg/mL. The effect of CBD on inflammatory cytokines in LPS-stimulated PBMCs tended to be dose-dependent, with CBD concentrations of 5–30 μg/mL resulting in decreased production of the tested pro-inflammatory cytokines. Considering the effect of CBD on cytokine production by PBMCs from epileptic dogs, CBD has the potential to modulate immune responses and provide benefits when used in combination with antiepileptic drugs. The findings provided evidence of CBD cytotoxicity and its effect on the alteration of pro-inflammatory cytokines in canine PBMCs.
format Article
id doaj-art-2febcd91c6134088938dc8ad5deabafa
institution DOAJ
issn 2076-2615
language English
publishDate 2024-12-01
publisher MDPI AG
record_format Article
series Animals
spelling doaj-art-2febcd91c6134088938dc8ad5deabafa2025-08-20T02:53:22ZengMDPI AGAnimals2076-26152024-12-011424368310.3390/ani14243683Cytotoxicity and Immunomodulatory Effects of Cannabidiol on Canine PBMCs: A Study in LPS-Stimulated and Epileptic DogsPhannicha Kosukwatthana0Oumaporn Rungsuriyawiboon1Jatuporn Rattanasrisomporn2Kanogwan Kimram3Natthasit Tansakul4Graduate Program in Animal Health and Biomedical Sciences, Faculty of Veterinary Medicine, Kasetsart University, Bangkok 10900, ThailandDepartment of Veterinary Technology, Faculty of Veterinary Technology, Kasetsart University, Bangkok 10900, ThailandDepartment of Companion Animal Clinical Sciences, Faculty of Veterinary Medicine, Kasetsart University, Bangkok 10900, ThailandKasetsart University Veterinary Teaching Hospital, Faculty of Veterinary Medicine, Kasetsart University, Bangkok 10900, ThailandDepartment of Pharmacology, Faculty of Veterinary Medicine, Kasetsart University, Bangkok 10900, ThailandCannabidiol, the primary non-psychoactive phytocannabinoid found in cannabis, has generated significant research interest due to its potential for biological effects, such as anti-inflammatory, analgesic, immunomodulatory, and anticonvulsant properties. Several studies have demonstrated the potential of CBD to alter inflammatory cytokines; however, data on CBD’s effects on cell viability and pro-inflammatory cytokines in target animals, such as dogs, are limited. Therefore, in this study, we investigated the effects of CBD on the cell viability and modulation of pro-inflammatory cytokines, such as interleukin (IL)-1β, IL-6, and tumor necrosis factor-α (TNF-α), in canine PBMCs stimulated with LPS. To evaluate the effect of CBD on neuroinflammation in epilepsy pathology, an independent study of five refractory epileptic dogs co-treated with CBD for 30 days was conducted. The current findings revealed that CBD concentrations of 16 µg/mL had a statistically significant effect on the viability of canine PBMCs with a calculated IC<sub>50</sub> of 15.54 µg/mL. The effect of CBD on inflammatory cytokines in LPS-stimulated PBMCs tended to be dose-dependent, with CBD concentrations of 5–30 μg/mL resulting in decreased production of the tested pro-inflammatory cytokines. Considering the effect of CBD on cytokine production by PBMCs from epileptic dogs, CBD has the potential to modulate immune responses and provide benefits when used in combination with antiepileptic drugs. The findings provided evidence of CBD cytotoxicity and its effect on the alteration of pro-inflammatory cytokines in canine PBMCs.https://www.mdpi.com/2076-2615/14/24/3683cannabidiolCBDepilepsycytokinescanine
spellingShingle Phannicha Kosukwatthana
Oumaporn Rungsuriyawiboon
Jatuporn Rattanasrisomporn
Kanogwan Kimram
Natthasit Tansakul
Cytotoxicity and Immunomodulatory Effects of Cannabidiol on Canine PBMCs: A Study in LPS-Stimulated and Epileptic Dogs
Animals
cannabidiol
CBD
epilepsy
cytokines
canine
title Cytotoxicity and Immunomodulatory Effects of Cannabidiol on Canine PBMCs: A Study in LPS-Stimulated and Epileptic Dogs
title_full Cytotoxicity and Immunomodulatory Effects of Cannabidiol on Canine PBMCs: A Study in LPS-Stimulated and Epileptic Dogs
title_fullStr Cytotoxicity and Immunomodulatory Effects of Cannabidiol on Canine PBMCs: A Study in LPS-Stimulated and Epileptic Dogs
title_full_unstemmed Cytotoxicity and Immunomodulatory Effects of Cannabidiol on Canine PBMCs: A Study in LPS-Stimulated and Epileptic Dogs
title_short Cytotoxicity and Immunomodulatory Effects of Cannabidiol on Canine PBMCs: A Study in LPS-Stimulated and Epileptic Dogs
title_sort cytotoxicity and immunomodulatory effects of cannabidiol on canine pbmcs a study in lps stimulated and epileptic dogs
topic cannabidiol
CBD
epilepsy
cytokines
canine
url https://www.mdpi.com/2076-2615/14/24/3683
work_keys_str_mv AT phannichakosukwatthana cytotoxicityandimmunomodulatoryeffectsofcannabidioloncaninepbmcsastudyinlpsstimulatedandepilepticdogs
AT oumapornrungsuriyawiboon cytotoxicityandimmunomodulatoryeffectsofcannabidioloncaninepbmcsastudyinlpsstimulatedandepilepticdogs
AT jatupornrattanasrisomporn cytotoxicityandimmunomodulatoryeffectsofcannabidioloncaninepbmcsastudyinlpsstimulatedandepilepticdogs
AT kanogwankimram cytotoxicityandimmunomodulatoryeffectsofcannabidioloncaninepbmcsastudyinlpsstimulatedandepilepticdogs
AT natthasittansakul cytotoxicityandimmunomodulatoryeffectsofcannabidioloncaninepbmcsastudyinlpsstimulatedandepilepticdogs